BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15039839)

  • 21. Potent cytotoxins produced by a microbial symbiont protect host larvae from predation.
    Lopanik N; Lindquist N; Targett N
    Oecologia; 2004 Mar; 139(1):131-9. PubMed ID: 14747940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical and biological aspects of marine sponges of the genus Xestospongia.
    Zhou X; Xu T; Yang XW; Huang R; Yang B; Tang L; Liu Y
    Chem Biodivers; 2010 Sep; 7(9):2201-27. PubMed ID: 20860025
    [No Abstract]   [Full Text] [Related]  

  • 23. Structure of bryostatin 20: a symbiont-produced chemical defense for larvae of the host bryozoan, Bugula neritina.
    Lopanik N; Gustafson KR; Lindquist N
    J Nat Prod; 2004 Aug; 67(8):1412-4. PubMed ID: 15332866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. bryA: an unusual modular polyketide synthase gene from the uncultivated bacterial symbiont of the marine bryozoan Bugula neritina.
    Hildebrand M; Waggoner LE; Liu H; Sudek S; Allen S; Anderson C; Sherman DH; Haygood M
    Chem Biol; 2004 Nov; 11(11):1543-52. PubMed ID: 15556005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme inhibitors from marine invertebrates.
    Nakao Y; Fusetani N
    J Nat Prod; 2007 Apr; 70(4):689-710. PubMed ID: 17362037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of bioactive metabolites from marine-derived filamentous fungi collected from tropical and sub-tropical coral reefs.
    Namikoshi M; Kobayashi H; Yoshimoto T; Meguro S; Akano K
    Chem Pharm Bull (Tokyo); 2000 Oct; 48(10):1452-7. PubMed ID: 11045449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Some results and prospects of studies in the area of marine biochemistry and biotechnology].
    Eliakov GB; Smonik VA; Kuznetsova TA; Mikhaĭlov VV
    Bioorg Khim; 1992; 18(10-11):1424-40. PubMed ID: 1299219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural products from marine organisms and their associated microbes.
    König GM; Kehraus S; Seibert SF; Abdel-Lateff A; Müller D
    Chembiochem; 2006 Feb; 7(2):229-38. PubMed ID: 16247831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bioactive compounds from marine sponges and cell culture of marine sponges].
    Zhang XY; Zhao QY; Xue S; Zhang W
    Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(1):10-5. PubMed ID: 11977585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current status of natural products from marine fungi and their potential as anti-infective agents.
    Bhadury P; Mohammad BT; Wright PC
    J Ind Microbiol Biotechnol; 2006 May; 33(5):325-37. PubMed ID: 16429315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs from the seas - current status and microbiological implications.
    Proksch P; Edrada RA; Ebel R
    Appl Microbiol Biotechnol; 2002 Jul; 59(2-3):125-34. PubMed ID: 12111137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigations of the marine flora and fauna of the Islands of Palau.
    John Faulkner D; Newman DJ; Cragg GM
    Nat Prod Rep; 2004 Feb; 21(1):50-76. PubMed ID: 15039835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New methods for medicinal chemistry--universal gene cloning and expression systems for production of marine bioactive metabolites.
    Dunlap WC; Jaspars M; Hranueli D; Battershill CN; Perić-Concha N; Zucko J; Wright SH; Long PF
    Curr Med Chem; 2006; 13(6):697-710. PubMed ID: 16529560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling the evolution of mutualistic symbioses.
    Friesen ML; Jones EI
    Methods Mol Biol; 2012; 804():481-99. PubMed ID: 22144168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing calcareous sponges and their associated bacteria for the discovery of new bioactive natural products.
    Roué M; Quévrain E; Domart-Coulon I; Bourguet-Kondracki ML
    Nat Prod Rep; 2012 Jul; 29(7):739-51. PubMed ID: 22660834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial symbionts: prospects for the sustainable production of invertebrate-derived pharmaceuticals.
    Piel J
    Curr Med Chem; 2006; 13(1):39-50. PubMed ID: 16457638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Marine resources and drugs: fishing for molecules].
    Biard JF
    Allerg Immunol (Paris); 2002 Oct; 34(8):293-6. PubMed ID: 12449668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symbiotic diversity in marine animals: the art of harnessing chemosynthesis.
    Dubilier N; Bergin C; Lott C
    Nat Rev Microbiol; 2008 Oct; 6(10):725-40. PubMed ID: 18794911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolutionary transitions in symbioses: dramatic reductions in bathymetric and geographic ranges of Zoanthidea coincide with loss of symbioses with invertebrates.
    Swain TD
    Mol Ecol; 2010 Jun; 19(12):2587-98. PubMed ID: 20497327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chemistry and biology of guanidine natural products.
    Berlinck RG; Romminger S
    Nat Prod Rep; 2016 Mar; 33(3):456-90. PubMed ID: 26689539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.